 |
|
Clinical Experience With Pancreaticoduodenal Transplantation
John E. Connolly, MD;
Donald C. Martin, MD;
Terry Steinberg, MD;
Grant Gwinup, MD;
Alan B. Gazzaniga, MD;
Robert H. Bartlett, MD
AMA Arch Surg. 1973;106(4):489-494.
Abstract
Three cases of human pancreaticoduodenal allografting are reported. One of the three patients showed no rejection of her transplanted pancreas for a period of ten months at which time she was killed in an automobile accident. She received no insulin following her transplant and maintained normal blood glucose and amylase levels. There was no evidence of progression of vascular disease during this period of successful transplantation.
The other two patients rejected their duodenal pancreases at five and six weeks, respectively. Clear rejection of a transplanted pancreas should be followed by prompt removal of the transplant. Management of pancreatic rejection in this way should preclude significant morbidity or loss of life due to the procedure.
Further human pancreas transplantation appears to be warranted utilizing the lessons learned.
Author Affiliations
Irvine, Calif
From the departments of surgery (Drs. Connolly, Martin, Gazzaniga, and Bartlett) and medicine (Drs. Steinberg and Gwinup), University of California at Irvine.
Footnotes
Accepted for publication Dec 15, 1972.
Read before the 80th annual meeting of the Western Surgical Association, Rochester, Minn, Nov 17, 1972.
Reprint requests to Department of Surgery, University of California at Irvine, Irvine, Calif 92664 (Dr. Connolly).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Hormonal and Metabolic Effects of a Pancreatic Endocrine Graft: Vascularized Segmental Transplantation in Insulin-Dependent Diabetic Patients
SUTHERLAND et al.
ANN INTERN MED 1981;95:537-541.
ABSTRACT
ACS/NIH Organ Transplant Registry: Third Scientific Report
Advisory Committee to the Registry
JAMA 1973;226:1211-1216.
ABSTRACT
|
